The closing price of Larimar Therapeutics Inc (NASDAQ: LRMR) was $11.74 for the day, down -5.25% from the previous closing price of $12.39. In other words, the price has decreased by -$0.65 from its previous closing price. On the day, 552455 shares were traded.
Ratios:
Our analysis of LRMR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 15.02 and its Current Ratio is at 15.02. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
On October 19, 2022, Guggenheim started tracking the stock assigning a Buy rating and target price of $12.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 16 when Flynn James E bought 4,290,617 shares for $8.74 per share. The transaction valued at 37,499,993 led to the insider holds 6,151,406 shares of the business.
THOMAS FRANK E bought 2,000 shares of LRMR for $22,000 on Feb 14. The Director now owns 2,000 shares after completing the transaction at $11.00 per share. On Dec 07, another insider, Shankar Gopi, who serves as the Chief Development Officer of the company, bought 5,000 shares for $3.73 each. As a result, the insider paid 18,662 and bolstered with 5,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LRMR now has a Market Capitalization of 752.26M and an Enterprise Value of 662.06M.
Stock Price History:
Over the past 52 weeks, LRMR has reached a high of $13.68, while it has fallen to a 52-week low of $2.18. The 50-Day Moving Average of the stock is 6.18, while the 200-Day Moving Average is calculated to be 4.21.
Shares Statistics:
LRMR traded an average of 429.22K shares per day over the past three months and 1.74M shares per day over the past ten days. A total of 43.27M shares are outstanding, with a floating share count of 17.72M. Insiders hold about 59.64% of the company’s shares, while institutions hold 50.65% stake in the company. Shares short for LRMR as of Jan 31, 2024 were 339.7k with a Short Ratio of 0.79, compared to 390.01k on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 0.77% and a Short% of Float of 1.31%.
Earnings Estimates
The firm’s stock currently is rated by 5 analysts. On average, analysts expect EPS of -$0.25 for the current quarter, with a high estimate of -$0.22 and a low estimate of -$0.28, while EPS last year was -$0.21. The consensus estimate for the next quarter is -$0.28, with high estimates of -$0.19 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$0.56 and -$0.86 for the fiscal current year, implying an average EPS of -$0.75. EPS for the following year is -$1.47, with 4 analysts recommending between -$1.28 and -$1.73.
